Surgical Technique and Complication Avoidance

Surgical Management of Movement Disorders

Volumn , Issue , 2005, Pages 45-62

  Rosenow, Joshua M ^a   Rezai, Ali R ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123417204     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14137-6     Document Type: Chapter

References (19)

1. Aziz TZ, Peggs D, Agarwal E, et al. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg 1992; 6:575-582.
2. Aziz TZ, Peggs D, Sambrook MA, et al. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991; 6:288-292.
3. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249:1436-1438.
4. Benabid AL, Pollak P, Gross C, et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson’s disease. Stereotact Funct Neurosurg 1994; 62:76-84.
5. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345: 91-95.
6. Rezai A, Hutchison W, Lozano A. Chronic subthalamic nucleus stimulation for Parkinson’s disease. Neurosurg Oper Atlas 1999; 8:196-207.
7. Sterio D, Zonenshayn M, Mogilner AY, et al. Neurophysiological refinement of subthalamic nucleus targeting. Neurosurgery 2002; 50:58-67; discussion 67-69.
8. Ashby P, Kim YJ, Kumar R, et al. Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. Brain 1999; 122: 1919-1931.
9. Benabid AL, Benazzouz A, Hoffmann D, et al. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord 1998; 13:119-125.
10. Pollak P, Krack P, Fraix V, et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson’s disease. Mov Disord 2002; 17: S155-S161.
11. Zonenshayn M, Rezai AR, Mogilner AY, et al. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000; 47:282-292; discussion 292-294.
12. Loddenkemper T, Pan A, Neme S, et al. Deep brain stimulation in epilepsy. J Clin Neurophysiol 2001; 18:514-532.
13. Limousin P, Speelman JD, Gielen F, et al. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999; 66:289-296.
14. Oh MY, Abosch A, Kim SH, et al. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002; 50:1268-1274.
15. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000; 342:461-468.
16. Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997; 42:292-299.
17. Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) or the globus pallidus interna (GPi) for treatment of advanced Parkinson’s disease. Tecnologica MAP Suppl 2001; 1-8.
18. Medtronic I. Deep Brain Stimulation 3387/89 Lead Kit: Implant Manual. Minneapolis, MN: Medtronic, Inc., 2002.
19. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 tesla. J Magn Reson Imaging 2002; 15:241-250.